KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Guardant Health (GH) Operating Expenses (2017 - 2026)

Guardant Health's Operating Expenses history spans 9 years, with the latest figure at $402.1 million for Q4 2025.

  • On a quarterly basis, Operating Expenses rose 22.67% to $402.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 billion, a 20.01% increase, with the full-year FY2025 number at $1.4 billion, up 20.01% from a year prior.
  • Operating Expenses hit $402.1 million in Q4 2025 for Guardant Health, up from $364.2 million in the prior quarter.
  • Over the last five years, Operating Expenses for GH hit a ceiling of $402.1 million in Q4 2025 and a floor of $186.5 million in Q1 2021.
  • Historically, Operating Expenses has averaged $275.5 million across 5 years, with a median of $265.5 million in 2023.
  • Biggest five-year swings in Operating Expenses: skyrocketed 82.12% in 2021 and later dropped 7.03% in 2024.
  • Tracing GH's Operating Expenses over 5 years: stood at $206.3 million in 2021, then soared by 32.33% to $273.0 million in 2022, then grew by 29.14% to $352.6 million in 2023, then fell by 7.03% to $327.8 million in 2024, then rose by 22.67% to $402.1 million in 2025.
  • Business Quant data shows Operating Expenses for GH at $402.1 million in Q4 2025, $364.2 million in Q3 2025, and $338.5 million in Q2 2025.